Claims for Patent: 11,291,739

✉ Email this page to a colleague

Summary for Patent: 11,291,739

Title:	System and methods for sterilizing enclosed spaces using ozone
Abstract:	Systems and methods for sterilizing an enclosed space using ozone are disclosed herein. Various embodiments of the devices and methods also provide for accelerated degradation of the ozone upon sterilization. The methods can include identifying enclosed spaces, sterilizing enclosed spaces through ozone generation, generating reports and transmitting the reports. The sterilization unit disclosed herein can sterilize a plurality of enclosed spaces, such as a fleet of medical response vehicles.
Inventor(s):	Steven J. JURAK, Anthony M. SORGE, SR.
Assignee:	Gene Therapy Systems
Application Number:	US17/031,014

Details for Patent 11,291,739

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Glaxosmithkline Biologicals	SHINGRIX	zoster vaccine recombinant, adjuvanted	Injection	125614	October 20, 2017	11,291,739	2040-09-24
Glaxosmithkline Biologicals	SHINGRIX	zoster vaccine recombinant, adjuvanted	For Injection	125614	July 23, 2021	11,291,739	2040-09-24
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,291,739

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
United States of America	9987388	⤷ Get Started Free
United States of America	9623140	⤷ Get Started Free
United States of America	2022280669	⤷ Get Started Free
United States of America	2021316034	⤷ Get Started Free
United States of America	2021015953	⤷ Get Started Free
United States of America	2019030204	⤷ Get Started Free
United States of America	2017281823	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.